Johnson & Johnson to Host Medical Devices & Diagnostics Business Review

NEW BRUNSWICK, N.J., May 25 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) will host a review of its Medical Devices & Diagnostics business for the investment community, beginning at 8:30 a.m. (Eastern Time) on Thursday, June 3rd.

Alex Gorsky, Worldwide Chairman, Medical Devices & Diagnostics (MD&D) for Johnson & Johnson, will host the meeting at the Hyatt Regency Hotel in New Brunswick, N.J. He will be joined by senior leaders of MD&D's seven franchises:  Cordis, DePuy, Diabetes Care, Ethicon, Ethicon Endo-Surgery, Ortho Clinical Diagnostics and Vision Care.

Investors and other interested parties may access the meeting by visiting the Johnson & Johnson website at www.investor.jnj.com for a simultaneous webcast of the presentation. A webcast and podcast replay will be available approximately two hours after the live webcast.

About Johnson & Johnson

Caring for the world, one person at a time...inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 114,000 employees at more than 250 Johnson & Johnson companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.

SOURCE Johnson & Johnson

Suggested Articles

After years of having first-line liver cancer market to itself, Bayer’s Nexavar is getting major competition from Roche's Tecentriq.

Most of the recent enthusiasm around AbbVie’s new drugs has centered on Skyrizi and Rinvoq, but elagolix wants a piece of the spotlight, too.

During David Loew's tenure, Sanofi Pasteur bought Protein Sciences, whose recombinant technology is being applied to a COVID-19 vaccine.